% | $
Quotes you view appear here for quick access.

iBio, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mofisher22 mofisher22 Apr 18, 2012 5:23 PM Flag

    Whats your fav other than IBIO!

    INVI, a real sleeper, their area is spinal cord damage, and attempting to prevent its extent, or hopefully to improve the already dis abled, a great stock to conduct dd on.AIS, Another choice, which is much more closer to being a "sure" thing, if there is ever a sure thing. Solid company, turned profitable last quarter, have partnerships in place with big pharma, are in drug delivery, rather than drug development, which therefore cuts out major biotech risks of failed clinical trials. I will throw out one more, psdv, a company that focuses on problens of the eye. Just recently won approval, along with their partner, alim, for a launch in latter half of this year in Europe, for a drug that is used to treat diabetes related eye disease. psdv has plenty of cash, they have revenue, and they have several new projects in the works. They have consistantly been in the $4 range, got beaten down a few months back to little over $1. Now over $2, and on the move in past week. took breather today. There is a good article in seeking alpha today about psdv. There you have it, one highly speculative, invo, which in lots of ways similar to ibio, and 2 other safer, but also with major potential, ais and psdv. I think some of you will find them worthwhile of your time glta

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.710.00(0.00%)Aug 28 4:00 PMEDT